Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

γ-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes.

  • Jalal Taneera
  • Z Jin
  • Yuesheng Jin
  • Sarheed Jabar Muhammed
  • Enming Zhang
  • Stefan Lang
  • S Albert Salehi
  • O Korsgren
  • Erik Renström
  • Leif Groop
  • B Birnir
Publishing year: 2012
Language: English
Pages: 1985-1994
Publication/Series: Diabetologia
Volume: 55
Issue: 7
Document type: Journal article
Publisher: Springer

Abstract english


γ-Aminobutyric acid (GABA) is a signalling molecule in the interstitial space in pancreatic islets. We examined the expression and function of the GABA signalling system components in human pancreatic islets from normoglycaemic and type 2 diabetic individuals.

METHODS: Expression of GABA signalling system components was studied by microarray, quantitative PCR analysis, immunohistochemistry and patch-clamp experiments on cells in intact islets. Hormone release was measured from intact islets.

RESULTS: The GABA signalling system was compromised in islets from type 2 diabetic individuals, where the expression of the genes encoding the α1, α2, β2 and β3 GABA(A) channel subunits was downregulated. GABA originating within the islets evoked tonic currents in the cells. The currents were enhanced by pentobarbital and inhibited by the GABA(A) receptor antagonist, SR95531. The effects of SR95531 on hormone release revealed that activation of GABA(A) channels (GABA(A) receptors) decreased both insulin and glucagon secretion. The GABA(B) receptor antagonist, CPG55845, increased insulin release in islets (16.7 mmol/l glucose) from normoglycaemic and type 2 diabetic individuals.

CONCLUSIONS/INTERPRETATION: Interstitial GABA activates GABA(A) channels and GABA(B) receptors and effectively modulates hormone release in islets from type 2 diabetic and normoglycaemic individuals.


  • Endocrinology and Diabetes
  • Gene expression
  • gamma-Aminobutyric acid
  • Human islets
  • Type 2 diabetes


  • Genomics, Diabetes and Endocrinology
  • Islet cell physiology
  • Diabetes - Islet Patophysiology
  • ISSN: 1432-0428
Erik Renström
E-mail: erik [dot] renstrom [at] med [dot] lu [dot] se

Principal investigator

Diabetes - Islet Patophysiology

+46 40 39 11 57

+46 40 39 11 57




Faculty of Medicine

+46 46 222 80 84

BMC F1306





Lund University Diabetes Centre, CRC, SUS Malmö, Jan Waldenströms gata 35, House 91:12. SE-214 28 Malmö. Telephone: +46 40 39 10 00